Pathway-based Drug Repurposing

Pathway-Based Drug Repurposing is a mechanism-based drug repurposing approach that identifies new therapeutic indications for existing drugs by analyzing their effects on disease-associated biological pathways rather than individual molecular targets.

32

Publications

2.8K

Citations

219

Authors

109

Institutions

Publications per year

2017–2026

27

Authors

219

  1. JP
    Juan P. Casas

    University College London, United Kingdom

    2 publications · 1.1K citations

    2

    h-index

  2. LG
    Luana Galver

    Illumina (United States), United States

    2 publications · 1.1K citations

    2

    h-index

  3. JP
    John P. Overington

    European Bioinformatics Institute, United Kingdom

    2 publications · 1.1K citations

    2

    h-index

  4. RS
    Rita Santos

    European Bioinformatics Institute, United Kingdom

    2 publications · 1.1K citations

    2

    h-index

  5. MM
    Marilena M. Bourdakou

    Academy of Athens, Greece

    2 publications · 127 citations

    2

    h-index

1–5 of 219

Venues

  1. Scientific Reports

    3 publications · 100 citations

    3

    h-index

  2. Drug Discovery Today Therapeutic Strategies

    2 publications · 404 citations

    2

    h-index

  3. Journal of Ethnopharmacology

    1 publications · 18 citations

    1

    h-index

  4. bioRxiv (Cold Spring Harbor Laboratory)

    Repository · 1 publications · 71 citations

    1

    h-index

  5. Genes

    1 publications · 14 citations

    1

    h-index

1–5